CSR push: NSE to invest Rs 380-cr for cancer facility at Tata Memorial Centre; India’s largest BMT centre to set up
🕒 1 min read
India’s largest equity bourse, NSE, will invest Rs 380 crore to build a new 11-storey multi-speciality cancer treatment block and India’s largest bone marrow transplant centre at TMH-run ACTREC in Navi Mumbai. Expected by July 2027, this CSR-funded facility aims to handle 1.3 lakh outpatient visits annually and over 600 BMTs, significantly addressing critical healthcare gaps for cancer patients.
Continue Reading
-
“Mahieka Was Simply Walking”: Hardik Pandya Slams Paparazzi For ‘Cheap Sensationalism’
-
Gold price prediction today: What’s the gold rate outlook for June 20, 2025; why a ‘sell on rise’ strategy makes sense?
-
Updates: Attackers Were Trailing Suvendu Adhikari’s Aide, Says BJP Leader’s Brother
-
Bhojshala Complex’s Disputed Area Declared Temple By Madhya Pradesh High Court
- Rupee drops to 85.86 vs dollar amid foreign outflows; RBI rate cut in focus
- Aviation ties: Air India restores codeshare with Air Canada; flyers get wider access across Canada
- Vijay Rallies Cadre Ahead Of Madurai Meet, Predicts TVK Win In 2026 Polls
- Woman, 22, Dies By Suicide After Husband Says No To Buying Phone: Cops
- Big cheer! Home loan rates head below 8% – how much will 1% RBI repo rate cut reduce your EMI or tenure? Check calculations
- IND vs ENG Live: Rain likely to play spoilsport as India eye 300 with four wickets still in hand